Parabolic Drugs Ltd Annually Results

Gross Sales

72.35

70.3

84.34

240.3

446.7

Excise Duty

0

0

8.88

11.15

16.32

Net Sales

72.35

70.3

75.46

229.15

430.36

Other Operating Income

0.81

4.6

1.7

4.24

20.25

Other Income

4.16

6.19

0

0

26.97

Total Income

77.32

81.09

77.16

233.39

477.6

Total Expenditure

89.79

121.67

383.58

311.33

520.76

PBIDT

-12.47

-40.58

-306.42

-77.94

-43.15

Interest

8.36

10.8

107.63

98.99

83.69

PBDT

-20.83

-51.38

-414.05

-176.93

-126.86

Depreciation

34.54

53.65

67.22

73.22

68.25

Minority Interest Before NP

0

0

0

0

0

Tax

1.76

3.06

4.43

130.32

-61.29

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-57.13

-108.09

-485.7

-380.47

-133.8

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-57.13

-108.09

-485.7

-380.47

-133.8

Extra-ordinary Items

0

0

0

0

26.97

Adjusted Profit After Extra-ordinary item

-57.13

-108.09

-485.7

-380.47

-160.78

EPS (Unit Curr.)

-9.3

-17.46

-78.48

-61.48

-21.62

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

61.89

61.89

61.89

61.89

61.88

Public Shareholding (Number)

0

3,84,96,287

3,79,74,587

3,79,74,587

3,81,82,936

Public Shareholding (%)

0

62.2

61.36

61.36

61.68

Pledged/Encumbered - No. of Shares

0

2,26,19,927

2,26,19,927

2,26,19,927

2,23,72,320

Pledged/Encumbered - % in Total Promoters Holding

0

96.68

94.58

94.58

94.36

Pledged/Encumbered - % in Total Equity

0

36.55

36.55

36.55

36.15

Non Encumbered - No. of Shares

0

7,75,800

12,97,500

12,97,500

13,36,759

Non Encumbered - % in Total Promoters Holding

0

3.32

5.42

5.42

5.63

Non Encumbered - % in Total Equity

0

1.25

2.09

2.09

2.16

PBIDTM(%)

-17.23

-57.72

-406.06

-34.01

-10.02

PBDTM(%)

-28.79

-73.08

-548.7

-77.21

-29.47

PATM(%)

-78.96

-153.75

-643.65

-166.03

-31.09